Appili Therapeutics to delist from TSX Oct 2, transfer to NEX Oct 5

Appili Therapeutics will delist its TSX Class A common shares on Oct. 2, 2026 after failing to meet continued listing requirements, and begin trading on the TSX Venture Exchange NEX Board on Oct. 5, 2026; ticker changes to APLI.H from APLI with no change to name or CUSIP.